↓ Skip to main content

Incorporação de novos medicamentos pela Comissão Nacional de Incorporação de Tecnologias do SUS, 2012 a junho de 2016

Overview of attention for article published in Ciência & Saúde Coletiva, August 2017
Altmetric Badge

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Incorporação de novos medicamentos pela Comissão Nacional de Incorporação de Tecnologias do SUS, 2012 a junho de 2016
Published in
Ciência & Saúde Coletiva, August 2017
DOI 10.1590/1413-81232017228.02002017
Pubmed ID
Authors

Rosângela Caetano, Rondineli Mendes da Silva, Érica Militão Pedro, Ione Ayala Gualandi de Oliveira, Aline Navega Biz, Pamela Santana

Abstract

The National Commission for incorporation of Health Technologies (CONITEC), established in 2011, advises the Ministry of Health in decisions related to the incorporation, exclusion or change of medicines, products and procedures in the Unified Health System (SUS).The study investigated the decision-making process, profile of demands and incorporation of new medicines in the SUS from January/2012 to June/2016, based on data available on the CONITEC website. All submissions were evaluated and characterized by technology and applicant type. The incorporations were analyzed according to the Anatomical-Therapeutic-Chemical classification, International Classification of Disease of the clinical indication and active record in the National Health Surveillance Agency. In the period, 485 submissions were received, 92.2% concerning requests for incorporation and 62.1% for medicines, of which 93 (30.1%) received a favorable recommendation for incorporation. Domestic demands were more successful than externally originated ones. Six unregistered drugs were incorporated. Infectious and parasitic diseases and musculoskeletal diseases constituted the main clinical indications. The recommendation of incorporation occurred mainly based on the additional clinical benefits and low budget impact.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 20%
Researcher 4 13%
Student > Doctoral Student 4 13%
Student > Ph. D. Student 2 7%
Professor 1 3%
Other 2 7%
Unknown 11 37%
Readers by discipline Count As %
Social Sciences 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Engineering 2 7%
Nursing and Health Professions 2 7%
Business, Management and Accounting 1 3%
Other 7 23%
Unknown 11 37%